Manjit Kooner's journey with Myelodysplastic Syndrome (MDS) has been a challenging one, marked by strength, resilience, and ...

Myelodysplastic syndromes (MDS) are clonal disorders of the hematopoietic stem cell characterized by ineffective hematopoiesis leading to peripheral cytopenias. Different processes are involved in ...

There’s some promising news for people living with myelodysplastic syndrome (MDS) as a new treatment option may reduce the ...

Myelodysplastic syndrome (MDS) comprises a group of clonal bone marrow disorders characterized by ineffective hematopoiesis and increased predisposition to acute myeloid leukemia. The causes of ...

Palak Dave discusses the potential role of artificial intelligence in improving the accuracy of myelodysplastic syndromes ...

A multimodal computational framework for patient stratification and prognosis prediction enables automatic identification of ...

The investigational immunotherapy bexmarilimab has been granted orphan drug designation from the FDA for patients with ...

The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...